Via Nova Therapeutics Raises $20M in Series A Financing

10 Sep, 2021

Via Nova Therapeutics Raises $20M in Series A Financing
Photo by Rikki Chan on Unsplash

– Via Nova Therapeutics is an Oakland, Calif.-based company established to discover and develop therapeutics for acute and subacute viral infections.
– The company closed raised $20m in Series A financing.
Aditum Bio made the investment.
– The new investment will be used to advance the development of four preclinical antiviral programs in-licensed from Novartis.

Biotechnology Life Science North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: